Daewon Pharm (003220) - Total Liabilities

Latest as of December 2025: ₩339.07 Billion KRW ≈ $229.78 Million USD

Based on the latest financial reports, Daewon Pharm (003220) has total liabilities worth ₩339.07 Billion KRW (≈ $229.78 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Daewon Pharm - Total Liabilities Trend (2011–2025)

This chart illustrates how Daewon Pharm's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Daewon Pharm's working capital to evaluate short-term liquidity relative to the company's equity base.

Daewon Pharm Competitors by Total Liabilities

The table below lists competitors of Daewon Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Shaver Shop Group Ltd AU:SSG	Australia	AU$71.65 Million
Jindal Poly Investment and Finance Company Limited NSE:JPOLYINVST	India	Rs416.70 Million
BICO Group AB ST:BICO	Sweden	Skr1.93 Billion
Laxmi Goldorna House Ltd NSE:LGHL	India	Rs1.19 Billion
TONGDAO LIEP.GR. DL-0001 F:6WT	Germany	€1.28 Billion
Siam Wellness Group Public Company Limited BK:SPA	Thailand	฿1.25 Billion
Seoyon Co Ltd KO:007860	Korea	₩2.05 Trillion
DIO Corporation KQ:039840	Korea	₩137.55 Billion

Liability Composition Analysis (2011–2025)

This chart breaks down Daewon Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 003220 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.19	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.28	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.55	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Daewon Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Daewon Pharm (2011–2025)

The table below shows the annual total liabilities of Daewon Pharm from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩339.07 Billion ≈ $229.78 Million	+13.47%
2024-12-31	₩298.81 Billion ≈ $202.50 Million	+22.60%
2023-12-31	₩243.73 Billion ≈ $165.17 Million	+19.02%
2022-12-31	₩204.78 Billion ≈ $138.78 Million	-3.03%
2021-12-31	₩211.18 Billion ≈ $143.11 Million	+72.47%
2020-12-31	₩122.44 Billion ≈ $82.98 Million	-0.71%
2019-12-31	₩123.32 Billion ≈ $83.57 Million	+33.69%
2018-12-31	₩92.24 Billion ≈ $62.51 Million	+56.15%
2017-12-31	₩59.07 Billion ≈ $40.03 Million	+12.16%
2016-12-31	₩52.67 Billion ≈ $35.69 Million	+14.28%
2015-12-31	₩46.09 Billion ≈ $31.23 Million	-0.04%
2014-12-31	₩46.11 Billion ≈ $31.25 Million	+24.99%
2013-12-31	₩36.89 Billion ≈ $25.00 Million	+7.86%
2012-12-31	₩34.20 Billion ≈ $23.18 Million	-6.23%
2011-12-31	₩36.47 Billion ≈ $24.72 Million	--

About Daewon Pharm

KO:003220 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$124.04 Million

₩183.04 Billion KRW

Market Cap Rank

#18454 Global

#829 in Korea

Share Price

₩8540.00

Change (1 day)

-2.95%

52-Week Range

₩8220.00 - ₩13600.00

All Time High

₩23535.34